본문 바로가기

보유기술

연구성과

강스템바이오텍은 세포치료제와 오가노이드 기반 플랫폼 기술을 중심으로 과학적 검증과 임상적 가능성을 동시에 갖춘 혁신 치료제를 개발하고 있습니다.

R&D Achievements

2018.09
Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial
Journal : Stem Cells Translational Medicine
2017.11
Exosomes derived from human umbilical cord blood mesenchymal stem cells stimulates rejuvenation of human skin
Journal : BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2017.08
Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts
Journal : Oncotarget
2017.02
Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion
Journal : Stem Cell Reviews and Reports
2017.01
Clinical Trial of Human Umbilical Cord Blood-derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies
Journal : STEM CELLS
2016.12
Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis
Journal : Cell Death & Disease
2016.10
Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice.
Journal : Biochemistry and Biophysics Reports
2015.12
Mica Nanoparticle, STB-HO Eliminates the Human Breast Carcinoma Cells by Regulating the Interaction of Tumor with its Immune Microenvironment
Journal : Scientific Reports
2015.04
Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation
Journal : STEM CELLS
2015.01
Rapid and Efficient Direct Conversion of Human Adult Somatic Cells into Neural Stem Cells by HMGA2/let-7b
Journal : Cell Reports

Company

About Us

인사말
비전 및 미션
연혁
오시는 길

Business

줄기세포 치료제

오가노이드

CDMO 사업

헬스&뷰티 사업

R&D

보유기술

Investors

공지사항

IR

PR